Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma, B-Cell × Filgrastim × Clear all

Phase

Phase 2 3 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma 10 Lymphoma, Non-Hodgkin 9 Lymphoma, Mantle-Cell 9 Lymphoma, Large-Cell, Immunoblastic 9 Lymphoma, Follicular 9 Leukemia, Myeloid, Acute 9 Burkitt Lymphoma 9 Leukemia, Lymphocytic, Chronic, B-Cell 8 Lymphoma, B-Cell, Marginal Zone 7 Leukemia, Myeloid, Chronic-Phase 7 Leukemia, Myeloid, Accelerated Phase 7 Leukemia 7 Congenital Abnormalities 7 Myelodysplastic Syndromes 6 Multiple Myeloma 6 Blast Crisis 6 Recurrence 5 Myeloproliferative Disorders 5 Lymphoma, T-Cell, Cutaneous 5 Leukemia, Hairy Cell 5 Hodgkin Disease 5 Dendritic Cell Sarcoma, Interdigitating 5 Sezary Syndrome 4 Primary Myelofibrosis 4 Pdgfra-Associated Chronic Eosinophilic Leukemia 4 Mycosis Fungoides 4 Leukemia, Neutrophilic, Chronic 4 Leukemia, Myelomonocytic, Juvenile 4

Interventions

fludarabine 2 Cyclophosphamide 2 zanubrutinib 1 pegfilgrastim 1 obinutuzumab 1 fludarabine phosphate 1 Resistance Training 1 Radiotherapy 1 Modafinil 1 Lenalidomide 1 Injections 1 Filgrastim 1 Blood Specimen Collection 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01541072 2016-11-01

PALM2

Centre Leon Berard

Phase NA Terminated

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡